- Category
- Small (2023-24)
- Udyam number
- UDYAM-RJ-17-0046505

Davadost Pharma Private Limited
About Davadost Pharma Private Limited
Data last updated:
Davadost Pharma Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 August 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U51100WB2014PTC203164. Its GSTIN is 08AACCO0551D1ZW (Rajasthan). The company holds 6 GST registrations, all of them active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹82.33 Lakh. It was formerly known as Oakwood Consulting Private Limited. It is led by directors including Nikita Choudhary and Sunil Rewachand Chandiramani.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2 Ho – Chi – Minh Sarani, Kolkata, West Bengal, India – 700071.
As per the financials filed for FY 2025, the company reported a revenue of ₹64.96 Cr, a growth of 25% compared to the previous year. For the same year it recorded a net profit of ₹1.99 Cr (net margin 3.1%) and EBITDA of ₹1.24 Cr (EBITDA margin 1.9%). Revenue has grown at a compounded annual rate (CAGR) of 74% over three years and 114% over five years.
The company has about 663 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Dawaa Dost. As per MCA filings, the company has open charges of ₹23.52 Lakh and satisfied charges of ₹50 Lakh on record. The company has 9 deals on record (5 rights issues, 3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹14.51 Cr; the latest was in August 2022.
Davadost Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0046505). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Davadost Pharma has one previous CIN (Corporate Identification Number): U74900WB2014PTC203164. The current CIN is U51100WB2014PTC203164, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51100WB2014PTC203164 | Current |
| U74900WB2014PTC203164 | Previous |
Recognitions & Rankings of Davadost Pharma
Contact details
Davadost Pharma Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address2 Ho – Chi – Minh Sarani, Kolkata, West Bengal, India – 700071
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Davadost Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Davadost Pharma operates one associated brand: Dawaa Dost. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Online pharmacy providing generic medicines, personal care, and health products | dawaadost.com |
Business activity
The main business activity of Davadost Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Davadost Pharma Private Limited, buy the company report.
Financials of Davadost Pharma Private Limited
FY 2025 filings availableDavadost Pharma Private Limited reported revenue of ₹64.96 Cr (up 25% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 114% over five years, including 25% growth in the latest year. EBITDA rose 125% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.24 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.99 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.9% | ||||
| Net Profit Margin | 3.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Davadost Pharma Private Limited, buy the company report.
Board of directors of Davadost Pharma Private Limited
Davadost Pharma has 6 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nikita Choudhary | Director | 19 Aug 2014 | 12 Years 2 Months | Current |
| Sunil Rewachand Chandiramani | Director | 07 Apr 2020 | 6 Years 7 Months | Current |
| Sundeep Bajoria Also directs: Coca Cola India Private Limited | Additional Director | 09 Apr 2025 | 1 Years 7 Months | Current |
| Amit Choudhary Also directs: Updater Services Limited, Waterlillies Infinite LLP, Ninenine Consumer Private Limited and 4 more | Director | 10 Oct 2018 | 8 Years 1 Months | Current |
| Yash Harlalka Also directs: Anvaya Growth LLP, Ninenine Consumer Private Limited, Dawaa Dost Retail Private Limited and 1 more | Director | 04 Oct 2021 | 5 Years 1 Months | Current |
| Punit Kumar Poddar | Director | 28 Oct 2019 | 7 Years 0 Months | Current |
Auditor
Davadost Pharma Private Limited is audited by S.K.BATWARA & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.K.BATWARA & CO | FY 2023 | 03450C |
Shareholding
The shareholding of Davadost Pharma Private Limited is on record for 5 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Davadost Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Oct 2022 | 100700831 | Hdfc Bank Limited | ₹23.52 Lakh | Open | |
| 24 Mar 2022 | 100562103 | Others | ₹50 Lakh | Satisfied |
To see the full charge records of Davadost Pharma Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Davadost Pharma Private Limited has 9 deals on record (5 rights issues, 3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹14.51 Cr; the latest was in August 2022.
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2022 | Rights issue | ₹3.03 Cr | Investors: S K Fincap Advisors Private Limited , 3 individuals |
| May 2022 | Funding round | ₹5.98 Cr | Investors: Aahi Family Trust, Thirteen Initiatives LLP , 2 individuals |
| Feb 2022 | Rights issue | ₹4.06 Cr | Investors: Tara Medicos Private Limited , Jhaveri Steel Plates LLP , 2 individuals |
| Jun 2021 | Rights issue | ₹6.94 Cr | Investors: Unicorn Infinite LLP , Tara Medicos Private Limited , 2 individuals |
| Feb 2020 | Funding round | ₹6.9 Cr | Investors: Decor Securities Private Limited , 3 individuals |
To see the full deal history of Davadost Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Davadost Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Davadost Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Davadost Pharma Private Limited has a workforce of 663 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 663 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 |
To see the full employee and EPFO history of Davadost Pharma Private Limited, buy the company report.
GST
Davadost Pharma has 6 GST registrations: 6 active. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AACCO0551D1ZW | Rajasthan | Active | 07 Dec 2018 |
| 07AACCO0551D1ZY | Delhi | Active | 10 Jan 2020 |
| 04AACCO0551D1Z4 | Chandigarh | Active | 14 Feb 2020 |
| 27AACCO0551D1ZW | Maharashtra | Active | 16 Feb 2021 |
To see the full GST registrations and return filing status of Davadost Pharma Private Limited, buy the company report.
Recent activity
Davadost Pharma Private Limited has 10 board changes on record since 2014: 6 appointments and 4 cessations. The latest: Sundeep Bajoria was appointed as Additional Director on 09 Apr 2025.
4 earlier events are in the company report.
Frequently asked questions
Davadost Pharma is an active private limited company based in Kolkata, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 August 2014 (12+ years old) and is registered under CIN U51100WB2014PTC203164.
Davadost Pharma has 6 current directors:
- Nikita Choudhary - Director
- Sunil Rewachand Chandiramani - Director
- Sundeep Bajoria - Additional Director
- Amit Choudhary - Director
- Yash Harlalka - Director
- Punit Kumar Poddar - Director
The latest financial statements of Davadost Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Davadost Pharma is 08AACCO0551D1ZW, registered in Rajasthan. The company has 6 GST registrations in all, of which 6 are active. Other active GSTINs include 07AACCO0551D1ZY (Delhi), 04AACCO0551D1Z4 (Chandigarh), 27AACCO0551D1ZW (Maharashtra).
The CIN (Corporate Identification Number) of Davadost Pharma is U51100WB2014PTC203164. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Davadost Pharma was incorporated on 19 August 2014, making it 12+ years old. It is registered with the Registrar of Companies, Kolkata.
Davadost Pharma has 9 deals on record (5 rights issues, 3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹14.51 Cr; the latest was in August 2022.
Sundeep Bajoria was appointed as Additional Director on 09 Apr 2025. Yash Harlalka ceased to be Additional Director on 07 Oct 2021. Badri Prasad Choudhary ceased to be Director on 04 Oct 2021. Davadost Pharma has 10 board changes on record in total.
Yes, Davadost Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-RJ-17-0046505).
The registered office of Davadost Pharma is at 2 Ho – Chi – Minh Sarani, Kolkata, West Bengal, India – 700071.

